160 related articles for article (PubMed ID: 20213409)
1. Current concepts on the molecular biology of osteosarcoma.
Gorlick R
Cancer Treat Res; 2009; 152():467-78. PubMed ID: 20213409
[TBL] [Abstract][Full Text] [Related]
2. Osteosarcoma.
Gorlick R; Khanna C
J Bone Miner Res; 2010 Apr; 25(4):683-91. PubMed ID: 20205169
[TBL] [Abstract][Full Text] [Related]
3. The etiology of osteosarcoma.
Ottaviani G; Jaffe N
Cancer Treat Res; 2009; 152():15-32. PubMed ID: 20213384
[TBL] [Abstract][Full Text] [Related]
4. Osteosarcoma: basic science and clinical implications.
Hayden JB; Hoang BH
Orthop Clin North Am; 2006 Jan; 37(1):1-7. PubMed ID: 16311106
[TBL] [Abstract][Full Text] [Related]
5. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.
Mohseny AB; Szuhai K; Romeo S; Buddingh EP; Briaire-de Bruijn I; de Jong D; van Pel M; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2009 Nov; 219(3):294-305. PubMed ID: 19718709
[TBL] [Abstract][Full Text] [Related]
6. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
[TBL] [Abstract][Full Text] [Related]
7. [Adjuvant chemotherapy for osteosarcoma in Japan--past, present and future].
Furuse K; Maeyama I; Morimoto K; Orito T
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1746-56. PubMed ID: 6591859
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma.
Ferrari S; Palmerini E
Curr Opin Oncol; 2007 Jul; 19(4):341-6. PubMed ID: 17545797
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide.
Bruheim S; Xi Y; Ju J; Fodstad O
Clin Cancer Res; 2009 Dec; 15(23):7161-9. PubMed ID: 19920113
[TBL] [Abstract][Full Text] [Related]
10. [Role of chemotherapy in treatment of osteosarcoma].
Perek D; Jurczyk-Procyk S
Pediatr Pol; 1995 Nov; 70(11):939-47. PubMed ID: 8677160
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.
Patiño-García A; Zalacaín M; Marrodán L; San-Julián M; Sierrasesúmaga L
J Pediatr; 2009 May; 154(5):688-93. PubMed ID: 19159907
[TBL] [Abstract][Full Text] [Related]
12. Molecular classification of osteosarcoma.
Lau CC
Cancer Treat Res; 2009; 152():459-65. PubMed ID: 20213408
[TBL] [Abstract][Full Text] [Related]
13. New aspects of cell biology in osteosarcoma.
Grundmann E; Ueda Y; Schneider-Stock R; Roessner A
Pathol Res Pract; 1995 Jul; 191(6):563-70. PubMed ID: 7479379
[TBL] [Abstract][Full Text] [Related]
14. Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Patiño-García A; Zalacain M; Folio C; Zandueta C; Sierrasesúmaga L; San Julián M; Toledo G; De Las Rivas J; Lecanda F
Clin Cancer Res; 2009 Aug; 15(16):5082-91. PubMed ID: 19671856
[TBL] [Abstract][Full Text] [Related]
15. [Tumoral biology of osteosarcoma].
Beck D
Chir Pediatr; 1985; 26(4):203-6. PubMed ID: 3907868
[No Abstract] [Full Text] [Related]
16. Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma.
Hauben EI; Arends J; Vandenbroucke JP; van Asperen CJ; Van Marck E; Hogendoorn PC
Eur J Hum Genet; 2003 Aug; 11(8):611-8. PubMed ID: 12891382
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome.
Hicks MJ; Roth JR; Kozinetz CA; Wang LL
J Clin Oncol; 2007 Feb; 25(4):370-5. PubMed ID: 17264332
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapies in bone sarcomas: current approach and future directions.
Yarber JL; Agulnik M
Expert Opin Investig Drugs; 2011 Jul; 20(7):973-9. PubMed ID: 21510829
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance and malignancy in human osteosarcoma.
Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for Bone Sarcoma in Adults.
Wagner MJ; Livingston JA; Patel SR; Benjamin RS
J Oncol Pract; 2016 Mar; 12(3):208-16. PubMed ID: 26962160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
